Year All 2026 2025 2024 2023 November 16, 2026 Alamar Biosciences Highlights NULISA Data in 46 Presentations at CTAD 2026, Including 10 Oral Presentations November 4, 2026 Alamar Biosciences to Participate in Upcoming Investor Conferences November 3, 2026 Alamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue Guidance November 3, 2026 Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine November 2, 2026 Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study October 28, 2026 Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology October 8, 2026 Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026 October 5, 2026 Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team September 24, 2026 Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment September 1, 2026 Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
November 16, 2026 Alamar Biosciences Highlights NULISA Data in 46 Presentations at CTAD 2026, Including 10 Oral Presentations
November 3, 2026 Alamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
November 3, 2026 Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine
November 2, 2026 Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
October 28, 2026 Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology
October 8, 2026 Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026
October 5, 2026 Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
September 24, 2026 Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
September 1, 2026 Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference